KAGAWAS-150
Active duodenal ulcer
Maintenance therapy for duodenal ulcer patients at low
doses after healing of an active duodenal ulcer.
Active Benign gastric ulcer
Treatment of gastric oesophageal reflux disease.
Treatment of Zollinger – Ellison syndrome.
Relief of digestive disorders symptoms caused by excess gastric acid (burning, indigestion, heartburn)
This is only the preview. Please check here for the full indication.
Dosage form: Hard capsule
Packaging: 10's x 6
Therapeutic area: ALIMENTARY TRACT AND METABOLISM
Active pharmaceutical ingredient: Nizatidin 150mg